Genmab A/S (GMAB)
USD 21.48
(2.63%)
USD 21.48
(2.63%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -14.09 Billion DKK | -51.65% |
| 2022 | -9.29 Billion DKK | -8.95% |
| 2021 | -8.53 Billion DKK | -22.92% |
| 2020 | -6.94 Billion DKK | -105.9% |
| 2019 | -3.37 Billion DKK | -532.57% |
| 2018 | -532.9 Million DKK | 60.45% |
| 2017 | -1.34 Billion DKK | -338.91% |
| 2016 | -307.02 Million DKK | 64.87% |
| 2015 | -873.86 Million DKK | -143.6% |
| 2014 | -358.73 Million DKK | -116.56% |
| 2013 | -165.65 Million DKK | -170.09% |
| 2012 | -61.33 Million DKK | -14.96% |
| 2011 | -53.35 Million DKK | -262.82% |
| 2010 | 32.76 Million DKK | 107.52% |
| 2009 | -435.79 Million DKK | -687.86% |
| 2008 | -55.31 Million DKK | 52.35% |
| 2007 | -116.08 Million DKK | 71.75% |
| 2006 | -410.86 Million DKK | -14.67% |
| 2005 | -358.31 Million DKK | 8.26% |
| 2004 | -390.56 Million DKK | -37.15% |
| 2003 | -284.77 Million DKK | -19.07% |
| 2002 | -239.17 Million DKK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -13.66 Billion DKK | 3.1% |
| 2024 Q2 | -3.31 Billion DKK | 75.75% |
| 2023 Q2 | -10.07 Billion DKK | 12.11% |
| 2023 Q4 | -14.09 Billion DKK | -4.58% |
| 2023 FY | -14.09 Billion DKK | -51.65% |
| 2023 Q3 | -13.48 Billion DKK | -33.85% |
| 2023 Q1 | -11.45 Billion USD | -23.27% |
| 2022 Q4 | -9.29 Billion DKK | 4.64% |
| 2022 Q1 | -8.65 Billion DKK | -1.44% |
| 2022 FY | -9.29 Billion DKK | -8.95% |
| 2022 Q2 | -9.18 Billion DKK | -6.09% |
| 2022 Q3 | -9.74 Billion DKK | -6.16% |
| 2021 Q3 | -8.29 Billion DKK | 8.21% |
| 2021 FY | -8.53 Billion DKK | -22.92% |
| 2021 Q2 | -9.03 Billion DKK | -20.23% |
| 2021 Q1 | -7.51 Billion DKK | -8.26% |
| 2021 Q4 | -8.53 Billion DKK | -2.89% |
| 2020 Q1 | -5.36 Billion DKK | -59.27% |
| 2020 Q4 | -6.94 Billion DKK | 18.87% |
| 2020 Q3 | -8.55 Billion DKK | -36.9% |
| 2020 Q2 | -6.24 Billion DKK | -16.39% |
| 2020 FY | -6.94 Billion DKK | -105.9% |
| 2019 FY | -3.37 Billion DKK | -532.57% |
| 2019 Q1 | -977.38 Million DKK | -83.41% |
| 2019 Q2 | -388.81 Million DKK | 60.22% |
| 2019 Q3 | -4.45 Billion DKK | -1045.64% |
| 2019 Q4 | -3.37 Billion DKK | 24.32% |
| 2018 Q2 | -1.08 Billion DKK | -13.63% |
| 2018 FY | -532.9 Million DKK | 60.45% |
| 2018 Q1 | -956.77 Million DKK | 29.0% |
| 2018 Q4 | -532.9 Million DKK | 40.53% |
| 2018 Q3 | -896.07 Million DKK | 17.58% |
| 2017 Q3 | -1.08 Billion DKK | -5.31% |
| 2017 FY | -1.34 Billion DKK | -338.91% |
| 2017 Q2 | -1.03 Billion DKK | -34.97% |
| 2017 Q1 | -764.41 Million DKK | -148.98% |
| 2017 Q4 | -1.34 Billion DKK | -24.03% |
| 2016 Q1 | -634.85 Million DKK | 27.35% |
| 2016 Q4 | -307.02 Million DKK | 61.46% |
| 2016 Q3 | -796.66 Million DKK | -24.15% |
| 2016 Q2 | -641.7 Million DKK | -1.08% |
| 2016 FY | -307.02 Million DKK | 64.87% |
| 2015 FY | -873.86 Million DKK | -143.6% |
| 2015 Q4 | -873.86 Million DKK | -49.61% |
| 2015 Q3 | -584.08 Million DKK | -59.18% |
| 2015 Q2 | -366.94 Million DKK | -11.79% |
| 2015 Q1 | -328.24 Million DKK | 8.5% |
| 2014 Q3 | -271.38 Million DKK | 30.93% |
| 2014 Q4 | -358.73 Million DKK | -32.19% |
| 2014 FY | -358.73 Million DKK | -116.56% |
| 2014 Q1 | -670.11 Million DKK | -304.54% |
| 2014 Q2 | -392.92 Million DKK | 41.36% |
| 2013 Q1 | -121.79 Million DKK | -98.59% |
| 2013 FY | -165.65 Million DKK | -170.09% |
| 2013 Q4 | -165.65 Million DKK | -572.28% |
| 2013 Q3 | -24.64 Million DKK | 86.16% |
| 2013 Q2 | -178.05 Million DKK | -46.19% |
| 2012 Q1 | -101.94 Million DKK | -91.08% |
| 2012 FY | -61.33 Million DKK | -14.96% |
| 2012 Q3 | -402.66 Million DKK | -241.03% |
| 2012 Q4 | -61.33 Million DKK | 84.77% |
| 2012 Q2 | -118.07 Million DKK | -15.82% |
| 2011 Q1 | -84.98 Million DKK | -359.36% |
| 2011 Q2 | -77.63 Million DKK | 8.65% |
| 2011 Q3 | -151.6 Million DKK | -95.29% |
| 2011 FY | -53.35 Million DKK | -262.82% |
| 2011 Q4 | -53.35 Million DKK | 64.81% |
| 2010 Q1 | -245.08 Million DKK | 43.76% |
| 2010 Q4 | 32.76 Million DKK | 108.3% |
| 2010 FY | 32.76 Million DKK | 107.52% |
| 2010 Q3 | -394.78 Million DKK | 4.62% |
| 2010 Q2 | -413.89 Million DKK | -68.88% |
| 2009 FY | -435.79 Million DKK | -687.86% |
| 2009 Q4 | -435.79 Million DKK | 0.0% |
| 2008 FY | -55.31 Million DKK | 52.35% |
| 2007 FY | -116.08 Million DKK | 71.75% |
| 2006 FY | -410.86 Million DKK | -14.67% |
| 2005 FY | -358.31 Million DKK | 8.26% |
| 2004 FY | -390.56 Million DKK | -37.15% |
| 2003 FY | -284.77 Million DKK | -19.07% |
| 2002 FY | -239.17 Million DKK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Absci Corporation | -72.59 Million USD | -19317.89% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 8676.487% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 853.875% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -18712566.26% |
| Apollomics, Inc. | -27.39 Million USD | -51358.295% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -2149717.76% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -15836.016% |
| Bicycle Therapeutics plc | -481.46 Million USD | -2827.927% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -10818.258% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 39081.832% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 339296.343% |
| Chimerix, Inc. | -25.51 Million USD | -55145.523% |
| CRISPR Therapeutics AG | -150.84 Million USD | -9245.355% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 8034.551% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -5011.424% |
| Fortress Biotech, Inc. | 7.66 Million USD | 184013.894% |
| Fortress Biotech, Inc. | 7.66 Million USD | 184013.894% |
| Gritstone bio, Inc. | 39.49 Million USD | 35797.645% |
| Allakos Inc. | -24.97 Million USD | -56344.444% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -65433.913% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -156255.368% |
| Cytokinetics, Incorporated | 642.37 Million USD | 2294.523% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -19549.304% |
| Innoviva, Inc. | 255.56 Million USD | 5616.057% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -152511.396% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 1915281.519% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -34645.637% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -251171.464% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -17671.643% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -36859.258% |
| ImmuCell Corporation | 10.99 Million USD | 128364.596% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -9045.226% |
| Incyte Corporation | -3.17 Billion USD | -343.988% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 88769.412% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -1186381.334% |
| Mustang Bio, Inc. | -3.73 Million USD | -377228.694% |
| MiMedx Group, Inc. | -33.9 Million USD | -41482.844% |
| MEI Pharma, Inc. | -3.7 Million USD | -380385.83% |
| MacroGenics, Inc. | -66.98 Million USD | -20945.01% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -193911.076% |
| Mereo BioPharma Group plc | -51.46 Million USD | -27289.302% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -93186.878% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -137916.448% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 39252.895% |
| Minerva Neurosciences, Inc. | 41 Million USD | 34479.365% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -63308.6% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -555337.352% |
| NextCure, Inc. | -6.47 Million USD | -217547.059% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -48725.852% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -27814.299% |
| Onconetix, Inc. | 5.33 Million USD | 264512.765% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -220890.751% |
| Opthea Limited | 28.15 Million USD | 50164.912% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 74450.45% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 204564.423% |
| PDS Biotechnology Corporation | -32.7 Million USD | -42998.362% |
| Precigen, Inc. | -481 Thousand USD | -2930669.231% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -80935.87% |
| Prime Medicine, Inc. | -27.94 Million USD | -50352.74% |
| PureTech Health plc | -167.19 Million USD | -8331.371% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -45577.532% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -51918.45% |
| Replimune Group, Inc. | 1.41 Million USD | 998471.105% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -117456.3% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 50821.405% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -608308.965% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | -2217.808% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -76018.302% |
| Sesen Bio, Inc. | -112.55 Million USD | -12424.766% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -198449.296% |
| Solid Biosciences Inc. | -47.75 Million USD | -29422.513% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -4698.832% |
| SciSparc Ltd. | -2.06 Million USD | -682563.438% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 12522.344% |
| TG Therapeutics, Inc. | 17.86 Million USD | 79021.733% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -93041.724% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -226977.964% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 4167.131% |
| UroGen Pharma Ltd. | 4.39 Million USD | 321143.043% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -58547.086% |
| XOMA Corporation | -29 Million USD | -48510.345% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 79586.89% |
| AbCellera Biologics Inc. | -55.94 Million USD | -25100.215% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -101639.319% |
| Cassava Sciences, Inc. | -121.13 Million USD | -11537.333% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 202408.356% |
| Precision BioSciences, Inc. | -85.41 Million USD | -16405.093% |
| Dyadic International, Inc. | -6.37 Million USD | -220921.969% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -167761.396% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -88376.746% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -46180.368% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -42288.069% |
| IGM Biosciences, Inc. | -72.6 Million USD | -19315.751% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -34128.481% |
| Acelyrin, Inc. | -216.9 Million USD | -6399.219% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -155273.085% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -83865.692% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -164908.891% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | -4349.965% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -18101.185% |
| Senti Biosciences, Inc. | 1.74 Million USD | 810272.414% |
| Mesoblast Limited | 55.96 Million USD | 25289.858% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -55636.992% |
| ChromaDex Corporation | -24.04 Million USD | -58520.259% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -1635113.998% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 23112.88% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -189423.315% |
| Seer, Inc. | -4.24 Million USD | -332376.415% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 8815.732% |
| Novavax, Inc. | -298.29 Million USD | -4625.874% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -154108.625% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 22960.247% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -285959.253% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -16991.416% |
| Celcuity Inc. | 6.78 Million USD | 207912.8% |
| ContextLogic Inc. | -232 Million USD | -5976.293% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -5716.482% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -12653.196% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 407.101% |
| Amarin Corporation plc | -191.04 Million USD | -7279.083% |
| AnaptysBio, Inc. | -18.15 Million USD | -77565.142% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -122408.039% |
| Aptorum Group Limited | 1.35 Million USD | 1038900.453% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -21273.34% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 329469.159% |
| Ardelyx, Inc. | 34.51 Million USD | 40946.662% |
| Celularity Inc. | 65.19 Million USD | 21724.482% |
| Omeros Corporation | 331.17 Million USD | 4356.649% |
| Humacyte, Inc. | -22.48 Million USD | -62592.342% |
| Immunocore Holdings plc | -358.59 Million USD | -3831.187% |
| IO Biotech, Inc. | -140.69 Million USD | -9919.261% |
| GT Biopharma, Inc. | -1.02 Million USD | -1380605.191% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -7389.64% |
| Summit Therapeutics Inc. | 34.67 Million USD | 40755.823% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -232447.014% |
| Pulmatrix, Inc. | -10.41 Million USD | -135226.87% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -12554.171% |
| Evogene Ltd. | -19.63 Million USD | -71698.92% |
| CorMedix Inc. | -43.05 Million USD | -32643.739% |
| BioLineRx Ltd. | 7.33 Million USD | 192261.941% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -11943.983% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -18677.473% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -7776.519% |
| scPharmaceuticals Inc. | -6.54 Million USD | -215285.791% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -95524.746% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -10311.374% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 1915281.519% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -76018.302% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -6672.064% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -15096.792% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -63149.282% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -7536.222% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -52778.953% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 115998.138% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -84352.796% |
| Daré Bioscience, Inc. | -5.15 Million USD | -273208.322% |
| bluebird bio, Inc. | 108.57 Million USD | 13084.13% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 3822.0% |
| DBV Technologies S.A. | -126.98 Million USD | -11001.224% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -7944.855% |
| Galecto, Inc. | -21.21 Million USD | -66345.136% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -207117.404% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -15267.928% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -20697.25% |
| GlycoMimetics, Inc. | -40.98 Million USD | -34295.991% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 12190.777% |
| ADMA Biologics, Inc. | 90.06 Million USD | 15751.855% |
| Clene Inc. | 3.34 Million USD | 422165.868% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | -3996.488% |
| Aptose Biosciences Inc. | -8.19 Million USD | -171922.526% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -450424.733% |
| Soligenix, Inc. | -4.95 Million USD | -284596.028% |
| Century Therapeutics, Inc. | 847 Thousand USD | 1664444.746% |
| Kura Oncology, Inc. | -20.11 Million USD | -69971.578% |
| Surrozen, Inc. | -32.66 Million USD | -43057.605% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -34345.096% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 773939.748% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -440844.636% |
| Autolus Therapeutics plc | -186.59 Million USD | -7454.703% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -28492.001% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 41237.504% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -59438.793% |
| GRI Bio, Inc. | -1.79 Million USD | -785685.953% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -156828.953% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 264237.156% |
| INmune Bio, Inc. | -25.41 Million USD | -55375.975% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 9438.792% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -27727.233% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -86654.122% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -151623.771% |
| Jaguar Health, Inc. | 29.39 Million USD | 48063.662% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -488543.383% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 37182.731% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 100213.628% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 44312.012% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 3829.849% |
| Verastem, Inc. | -37.27 Million USD | -37715.87% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -27081.752% |
| Histogen Inc. | -7.48 Million USD | -188186.363% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -65143.289% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -10624.067% |
| Surrozen, Inc. | -32.66 Million USD | -43057.605% |
| Organovo Holdings, Inc. | -1.5 Million USD | -935334.638% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -335264.345% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -168098.875% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -32350.163% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -96608.07% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -1952230.831% |
| Kronos Bio, Inc. | -36.05 Million USD | -38999.685% |
| Turnstone Biologics Corp. | -14.58 Million USD | -96560.724% |
| Synaptogenix, Inc. | -28.66 Million USD | -49084.449% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -1505989.744% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 2244845.223% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 29027.604% |
| Exelixis, Inc. | -73.05 Million USD | -19197.741% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -58605.701% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -5740.387% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -16661.989% |
| ESSA Pharma Inc. | -33.62 Million USD | -41828.423% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -535471.816% |
| Avid Bioservices, Inc. | 169.72 Million USD | 8405.642% |
| Insmed Incorporated | 721.62 Million USD | 2053.521% |
| MediWound Ltd. | -5.32 Million USD | -264781.623% |
| OmniAb, Inc. | 9.2 Million USD | 153278.311% |
| Alector, Inc. | -35.63 Million USD | -39457.202% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 16497.39% |
| Zai Lab Limited | -775 Million USD | -1718.968% |
| AlloVir, Inc. | -62.69 Million USD | -22386.123% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 4239.419% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -106930.598% |
| Aura Biosciences, Inc. | -21.52 Million USD | -65391.289% |
| Immunic, Inc. | -45.34 Million USD | -30991.751% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -7196.017% |
| Veracyte, Inc. | -203.82 Million USD | -6816.261% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 2308.546% |
| FibroGen, Inc. | 56.76 Million USD | 24933.09% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 158404.323% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -10413.951% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -498541.355% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -680800.023% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -421839.539% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -8394.011% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 998.241% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -57504.609% |
| XBiotech Inc. | -200.02 Million USD | -6947.69% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -16661.989% |
| Keros Therapeutics, Inc. | -316.7 Million USD | -4351.173% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -817591.415% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 311429.505% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -39876.746% |
| Agenus Inc. | 274.13 Million USD | 5242.338% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -18156.106% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 247806.906% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -8172.159% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -15160.788% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 2014.661% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -130821.135% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -25247.934% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -408192.358% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -156951.212% |
| Lantern Pharma Inc. | -21.7 Million USD | -64853.322% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -333241.215% |
| Ainos, Inc. | 4.07 Million USD | 345790.262% |
| Pluri Inc. | 22.82 Million USD | 61850.405% |
| Prothena Corporation plc | -608.34 Million USD | -2217.263% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -11770.558% |
| Rallybio Corporation | -24.1 Million USD | -58388.922% |
| Kodiak Sciences Inc. | -103.87 Million USD | -13471.119% |
| Cue Biopharma, Inc. | -33.81 Million USD | -41583.669% |
| MeiraGTx Holdings plc | -40.3 Million USD | -34878.413% |
| Annexon, Inc. | -193.75 Million USD | -7175.683% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -80458.889% |
| Moderna, Inc. | -2.9 Billion USD | -384.933% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -57263.174% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -45519.883% |
| Blueprint Medicines Corporation | 702.83 Million USD | 2105.731% |
| Immix Biopharma, Inc. | -17.5 Million USD | -80409.242% |
| CalciMedica, Inc. | -5.53 Million USD | -254818.626% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -17078.475% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -35109.931% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -8279.45% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -42293.168% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -235754.107% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -23416.944% |
| Nutriband Inc. | -251.65 Thousand USD | -5601572.117% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -41217.155% |
| Vor Biopharma Inc. | 4.3 Million USD | 327937.209% |
| Roivant Sciences Ltd. | -6.03 Billion USD | -133.55% |
| Alkermes plc | -166.73 Million USD | -8354.531% |
| ProKidney Corp. | -56.23 Million USD | -24967.572% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -28863.264% |
| Arcellx, Inc. | -296.95 Million USD | -4647.136% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 1133.578% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -51227.144% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 30648.031% |
| Atai Life Sciences N.V. | -28.55 Million USD | -49262.7% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 632102.543% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -61685.589% |
| MediciNova, Inc. | -50.78 Million USD | -27659.007% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -17788.459% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -62667159.391% |
| GeoVax Labs, Inc. | -6.45 Million USD | -218370.447% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -6954.814% |
| Biomea Fusion, Inc. | -166.57 Million USD | -8363.109% |
| RenovoRx, Inc. | -1.17 Million USD | -1201690.281% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -14763.355% |
| Geron Corporation | 14.76 Million USD | 95601.66% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 308838.502% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -5913.129% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -14863.221% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -14631.023% |
| Royalty Pharma plc | 5.65 Billion USD | 349.14% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -35978.622% |
| Imunon, Inc. | -4.21 Million USD | -334439.514% |
| BioAtla, Inc. | -109.01 Million USD | -12831.722% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 117908.792% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -66385.875% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -9916.983% |
| Structure Therapeutics Inc. | -124.33 Million USD | -11237.551% |
| 89bio, Inc. | -289.05 Million USD | -4776.96% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -85026.812% |
| aTyr Pharma, Inc. | -7.44 Million USD | -189146.879% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -11210.536% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -17137.922% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -1640642.844% |
| Akari Therapeutics, Plc | -3.84 Million USD | -366531.99% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 868735.582% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 1120.872% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 16962.642% |
| Liquidia Corporation | -80.17 Million USD | -17482.568% |
| Entera Bio Ltd. | -10.62 Million USD | -132527.717% |
| GH Research PLC | -78.07 Million USD | -17955.253% |
| Vericel Corporation | 1.27 Million USD | 1104015.427% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -80160.761% |
| Xencor, Inc. | 29.64 Million USD | 47654.311% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -715552.052% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -86654.122% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -5755939.002% |
| Vaxcyte, Inc. | -368.22 Million USD | -3728.345% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -10134.5% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -11051.19% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -1186381.334% |
| Portage Biotech Inc. | -4.98 Million USD | -282915.459% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -62667159.391% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -21219.682% |
| OncoCyte Corporation | -6.56 Million USD | -214695.063% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 1570948.651% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -309340.402% |
| Purple Biotech Ltd. | -14.13 Million USD | -99610.001% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -75816.851% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -240463.14% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -23865.931% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -59240.798% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -61255.327% |
| United Therapeutics Corporation | -507.7 Million USD | -2676.64% |
| HilleVax, Inc. | -165.48 Million USD | -8418.597% |
| Silo Pharma, Inc. | -3.52 Million USD | -399893.417% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 14129739.467% |
| Pharming Group N.V. | 109.8 Million USD | 12938.33% |
| Tharimmune, Inc. | -10.93 Million USD | -128812.174% |
| Genprex, Inc. | -6.73 Million USD | -209127.905% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -12023.114% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | -3722.324% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 138373.664% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -1006109.85% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -424899.382% |
| OKYO Pharma Limited | -826.84 Thousand USD | -1704808.278% |
| Savara Inc. | 153 Thousand USD | 9213825.49% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 112776.844% |
| Curis, Inc. | -23.88 Million USD | -58915.364% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -1816495.62% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 1189720.253% |
| BeiGene, Ltd. | -2.25 Billion USD | -525.675% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -7495.939% |
| Erasca, Inc. | -37.21 Million USD | -37778.869% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -1094478.509% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -1094478.509% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -136076.584% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -129611.078% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -44836.406% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -43581.829% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -40908.262% |
| Adicet Bio, Inc. | -138.78 Million USD | -10057.291% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 7217.36% |
| Aditxt, Inc. | 18.12 Million USD | 77894.214% |
| Adagene Inc. | -87.62 Million USD | -15987.436% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -338328.608% |
| Quantum-Si incorporated | -118.55 Million USD | -11790.483% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -188509.117% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -28960.587% |
| Compugen Ltd. | -12.9 Million USD | -109145.195% |
| Generation Bio Co. | 31.44 Million USD | 44926.38% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -7938.708% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -45487.427% |
| Invivyd, Inc. | -198.47 Million USD | -7002.622% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -15516.484% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -587841.317% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -19813.83% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -206449.451% |
| 2seventy bio, Inc. | 181.71 Million USD | 7857.753% |
| Instil Bio, Inc. | 75.35 Million USD | 18806.707% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -155107.101% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -452254.38% |
| GeoVax Labs, Inc. | -6.45 Million USD | -218370.447% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -54119.892% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -344437.924% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -270527.76% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -10718.547% |
| Evaxion Biotech A/S | 5.28 Million USD | 266743.01% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -12423.097% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -10638.69% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -27267.501% |
| Cingulate Inc. | 3.08 Million USD | 457396.452% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -479879.571% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 196245.819% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -13256.768% |
| Clearmind Medicine Inc. | -3.94 Million USD | -357452.572% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 149924.636% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 966888.215% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -25882.38% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 81689.304% |
| ImmunityBio, Inc. | 618.22 Million USD | 2380.241% |
| Korro Bio, Inc. | -132.94 Million USD | -10503.793% |
| Kineta, Inc. | -4.54 Million USD | -310338.229% |
| BioVie Inc. | -17.73 Million USD | -79398.765% |
| Codexis, Inc. | -43.27 Million USD | -32478.401% |
| Celularity Inc. | 65.19 Million USD | 21724.482% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 19119.158% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -444740.644% |
| Virax Biolabs Group Limited | -3.36 Million USD | -418837.135% |
| Cibus, Inc. | -8.07 Million USD | -174411.018% |
| IN8bio, Inc. | -16.38 Million USD | -85915.01% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 39158433.333% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -401180.956% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 1437.13% |
| Eyenovia, Inc. | 1.25 Million USD | 1120063.264% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 52495.466% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -434590.102% |
| Elevation Oncology, Inc. | -19.11 Million USD | -73636.793% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -42300.818% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -72170.071% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -23843.949% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -67912.737% |
| Moolec Science SA | 117.61 Thousand USD | 11985714.202% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -36611.894% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -37077.594% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -9868.109% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -62567.259% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -201590.44% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -262763.521% |
| Humacyte, Inc. | -22.48 Million USD | -62592.342% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -55747.397% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -790533.763% |
| Genelux Corporation | -6.89 Million USD | -204233.961% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -45287.81% |
| Notable Labs, Ltd. | -9.77 Million USD | -144100.082% |
| Immunovant, Inc. | -635.22 Million USD | -2119.207% |
| Quantum-Si incorporated | -118.55 Million USD | -11790.483% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -340160.681% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 175719.783% |
| Acasti Pharma Inc. | -23 Million USD | -61177.983% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -418552.845% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -8227.721% |
| PepGen Inc. | -60.67 Million USD | -23135.537% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -73605.95% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -1635113.998% |
| Immuneering Corporation | -54.94 Million USD | -25557.566% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -335264.345% |
| Belite Bio, Inc | -87.27 Million USD | -16053.132% |
| XOMA Corporation | -29 Million USD | -48510.345% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -19840.026% |
| Bionomics Limited | 227 Million USD | 6309.862% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -556433.754% |
| uniQure N.V. | -102.95 Million USD | -13592.922% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -338328.608% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 34524.068% |
| Forte Biosciences, Inc. | -11.96 Million USD | -117758.039% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -455494.338% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 13299156.604% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -434590.102% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 158404.323% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -189988.997% |
| Altimmune, Inc. | -134.48 Million USD | -10382.054% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -7499.502% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -556433.754% |
| Peak Bio, Inc. | 10.34 Million USD | 136432.54% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -4981172.085% |
| Benitec Biopharma Inc. | -50.58 Million USD | -27769.598% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -13410.897% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 71858.717% |
| Zura Bio Limited | -99.8 Million USD | -14024.401% |
| PolyPid Ltd. | 6.17 Million USD | 228576.499% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 71858.717% |
| argenx SE | -2.02 Billion USD | -594.829% |
| Immunome, Inc. | -97.02 Million USD | -14428.646% |
| Verona Pharma plc | -220.44 Million USD | -6294.85% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -19549.304% |
| Shattuck Labs, Inc. | -121.42 Million USD | -11509.731% |
| CervoMed Inc. | -7.79 Million USD | -180796.684% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -322264.509% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -10600.623% |
| Moolec Science SA | 117.61 Thousand USD | 11985714.202% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -616033.816% |
| Design Therapeutics, Inc. | -18.15 Million USD | -77569.421% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -19929.553% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 125607.479% |
| Achilles Therapeutics plc | -126.92 Million USD | -11006.647% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 966888.215% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -189375.806% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 4243.776% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 59493.301% |
| MoonLake Immunotherapeutics | -447.47 Million USD | -3050.368% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -9946.967% |
| Beam Therapeutics Inc. | -262.72 Million USD | -5265.748% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 64717.712% |
| AEON Biopharma, Inc. | -4.88 Million USD | -288772.951% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -25134.498% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -14016.763% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -600336.239% |
| NeurAxis, Inc. | 145.7 Thousand USD | 9675460.329% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -36022.072% |
| Lumos Pharma, Inc. | -28.49 Million USD | -49375.31% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -67759.434% |
| Palisade Bio, Inc. | -12.06 Million USD | -116761.477% |
| Nutriband Inc. | -251.65 Thousand USD | -5601572.117% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -16826.827% |
| Neurogene Inc. | -131.95 Million USD | -10583.187% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -287066.429% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | -3637.364% |
| Athira Pharma, Inc. | -88.99 Million USD | -15739.504% |
| HCW Biologics Inc. | 2.85 Million USD | 493575.634% |
| XOMA Corporation | -29 Million USD | -48510.345% |
| Nektar Therapeutics | 210.24 Million USD | 6805.194% |
| Arvinas, Inc. | -313.8 Million USD | -4392.352% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 868735.582% |
| Merus N.V. | -192.88 Million USD | -7208.538% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 23600.875% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -203085.356% |
| Rezolute, Inc. | -68.16 Million USD | -20579.791% |
| Clene Inc. | 3.34 Million USD | 422165.868% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -106800.736% |
| BeyondSpring Inc. | -13.75 Million USD | -102386.369% |
| Synlogic, Inc. | -6.68 Million USD | -210775.093% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 1243221.693% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -166629.746% |
| Peak Bio, Inc. | 10.34 Million USD | 136432.54% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -17003.858% |
| Krystal Biotech, Inc. | -350.23 Million USD | -3925.023% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 11457.1% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -8241.618% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -446411.151% |
| MannKind Corporation | 143.89 Million USD | 9896.454% |
| Ikena Oncology, Inc. | -109.15 Million USD | -12814.544% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -186097.332% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -42489.124% |
| Gossamer Bio, Inc. | 180.35 Million USD | 7916.251% |
| CohBar, Inc. | -5.93 Million USD | -237594.139% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -47288.06% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 308838.502% |
| Legend Biotech Corporation | -949.39 Million USD | -1384.836% |
| Mural Oncology plc | -255.84 Million USD | -5410.02% |
| Disc Medicine, Inc. | -358.28 Million USD | -3834.621% |
| Champions Oncology, Inc. | 4.81 Million USD | 293055.112% |
| REGENXBIO Inc. | 54.76 Million USD | 25839.483% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -5242232.851% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -9234.278% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -156324.663% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -17372.082% |
| Vaxart, Inc. | -8.24 Million USD | -170959.337% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -27992.884% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -10985.54% |
| Cellectis S.A. | -43.85 Million USD | -32044.567% |
| Longeveron Inc. | -2.9 Million USD | -484666.162% |
| Repare Therapeutics Inc. | -107.85 Million USD | -12969.962% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 1555.733% |
| Inozyme Pharma, Inc. | 12 Million USD | 117535.855% |
| Revolution Medicines, Inc. | -608.2 Million USD | -2217.808% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -1145997.561% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -5217.275% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -9293.491% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -89993.948% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -1904900.0% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | -47.398% |
| Denali Therapeutics Inc. | -74.86 Million USD | -18729.894% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -117456.3% |
| Veru Inc. | 4.77 Million USD | 295018.231% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -125251.236% |
| Cingulate Inc. | 3.08 Million USD | 457396.452% |
| Passage Bio, Inc. | 4.58 Million USD | 307559.106% |
| Context Therapeutics Inc. | -14.44 Million USD | -97458.261% |
| Exicure, Inc. | 5.84 Million USD | 241115.558% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -6019.127% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -35525.474% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 89941.31% |
| Nuvalent, Inc. | -335.38 Million USD | -4103.204% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 812915.934% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -18826.721% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -158471.429% |
| OmniAb, Inc. | 9.2 Million USD | 153278.311% |
| Anew Medical, Inc. | 1.43 Million USD | 984207.814% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 86153.051% |
| Lipocine Inc. | -4.75 Million USD | -296392.317% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -12735.525% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 92654.658% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -27727.233% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 56732.653% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -209645.574% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -21315.225% |
| Ocugen, Inc. | -32.52 Million USD | -43247.376% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -16373.269% |
| Q32 Bio Inc. | -37.94 Million USD | -37048.203% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -2244645.223% |
| Alumis Inc. Common Stock | -13.52 Million USD | -104098.389% |
| Equillium, Inc. | -22.39 Million USD | -62855.52% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -55035.325% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -43106.854% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -5686123.101% |
| Dominari Holdings Inc. | 195 Thousand USD | 7229330.769% |
| Edesa Biotech, Inc. | -5.26 Million USD | -267552.191% |
| vTv Therapeutics Inc. | -8.91 Million USD | -157991.286% |
| Bio-Techne Corporation | 267.74 Million USD | 5365.045% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -86870.202% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -11837.101% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -167661.514% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -111329.926% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -5651.084% |
| Nkarta, Inc. | 57.29 Million USD | 24702.524% |
| BioCardia, Inc. | 212 Thousand USD | 6649628.302% |
| Iterum Therapeutics plc | 13.43 Million USD | 105004.004% |